Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
1204 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.500 | 18 | 2005 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||
Liver carcinoma
|
942 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 1.000 | 7 | 2006 | 2019 | ||||
Alzheimer's Disease
|
1843 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||
Carcinogenesis
|
355 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.040 | 1.000 | 4 | 2005 | 2019 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.030 | 0.667 | 3 | 2011 | 2019 | ||||
Esophageal carcinoma
|
272 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.030 | 0.667 | 3 | 2001 | 2019 | ||||
Esophageal Neoplasms
|
270 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.030 | 0.667 | 3 | 2001 | 2019 | ||||
Malignant neoplasm of esophagus
|
214 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.030 | 0.667 | 3 | 2001 | 2019 | ||||
cervical cancer
|
268 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Cervix carcinoma
|
283 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Malignant tumor of cervix
|
245 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Carcinoma in situ of uterine cervix
|
18 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Cervical Intraepithelial Neoplasia
|
29 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Cervical Squamous Cell Carcinoma
|
44 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis C
|
347 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis C, Chronic
|
80 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Human papilloma virus infection
|
42 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Myeloid Leukemia, Chronic
|
115 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Papilloma
|
27 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 |